SCHEMBL17665147

SCHEMBL17665147

COC1CCCN(C(=O)[C@H](C)O)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.49
DPP7 Q9UHL4 1/20 0.49
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
PDE9A O76083 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HRH3 Q9Y5N1 3/20 0.36
PDE4B Q07343 1/20 0.36
PIK3CD O00329 1/20 0.36
HSD11B1 P28845 1/20 0.36
ROCK2 O75116 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.35
PRMT5 O14744 1/20 0.34
TP53 P04637 1/20 0.34
KDM4E B2RXH2 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12521996 0.93 KMT2A (0.43) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL10328343 0.93 KMT2A (0.43) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL17665018 0.87 DPP4 (0.46) DPP4DPP7PDE9ANPC1RAB9A
SCHEMBL21204487 0.87 DPP4 (0.46) DPP4DPP7PDE9ANPC1RAB9A
SCHEMBL17665019 0.87 DPP4 (0.46) DPP4DPP7PDE9ANPC1RAB9A
SCHEMBL17660723 0.85 DPP4 (0.41) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL12521649 0.83 PDE9A (0.40) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL16132288 0.83 PDE9A (0.40) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL17308197 0.83 PDE9A (0.40) DPP4DPP7KMT2AALDH1A1MEN1
SCHEMBL17308204 0.83 PDE9A (0.40) DPP4DPP7KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3517536-B1 AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-05-05 EP disclosed
EP-3517536-A1 AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS Gilead Sciences, Inc. (US) 2019-07-31 EP disclosed
US-20160096827-A1 TANK-BINDING KINASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160096827-A1 TANK-BINDING KINASE INHIBITOR COMPOUNDS TBKBP1, TNKS1BP1, TNKS DPP4 3256/4885DPP7 2228/4885KMT2A 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.